发明名称 |
Controlled release formulation |
摘要 |
The present invention discloses a controlled release formulation suitable for oral administration comprising N<SUP>6</SUP>-cyclopentyl-5'-(N-ethyl)carboxamidoadenosine or a pharmaceutically acceptable salt or ester thereof incorporated in a controlled release matrix. The controlled release formulation of the invention is especially suitable for treating heart rhythm disturbances in a mammal.
|
申请公布号 |
US2005118262(A1) |
申请公布日期 |
2005.06.02 |
申请号 |
US20040943147 |
申请日期 |
2004.09.17 |
申请人 |
AURORA JACK;GILL MANMOHAN S.;ONG KENNETH K.H. |
发明人 |
AURORA JACK;GILL MANMOHAN S.;ONG KENNETH K.H. |
分类号 |
A61K9/14;A61K9/16;A61K9/20;A61K9/48;A61K36/47;(IPC1-7):A61K31/707;A61K9/22;A61K35/78 |
主分类号 |
A61K9/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|